close
close

Pharmaceutical Sector: A Change for the Better, 6 Small and Medium Pharma Companies with Growth Potential of Up to 32%

Posted on by darion

Pharmaceutical Sector: A Change for the Better, 6 Small and Medium Pharma Companies with Growth Potential of Up to 32%

IANS

summary

While it didn’t make headlines, the pharmaceutical sector, commonly known as pharma, has been going through a rough patch due to the US FDA and other factors. It has seen a turnaround of sorts, which has been slow, but more and more companies are showing improvement in their performance. The sector is also quietly undergoing a reassessment process. First, the big players got the attention, followed by the small and mid-sized players. If we look at corporate announcements regarding drug approvals by the US FDA or other drug regulators or entering new markets, many of them come from mid-sized and small companies. Given the lesson that the Indian pharma industry has learnt from its reckless approach between 2005 and 2015, there is a strong possibility that the sector will gain attention.

By ETMarkets.com

11 minutes of reading,

Although ‘turn around’ is a general word, each sector has a different matrix when it comes to turnaround. Both how it evolves and how long it takes. From manufacturing to services, the cycle is different. In the case of manufacturing, where knowledge plays an important role, the turnaround time can be long but more sustainable. The Indian pharmaceutical sector has undergone significant changes over the last decade, which means

To read the full story, become an ET Prime member

Get access to exclusive Economic Times articles, editorial and expert opinions

Monsoon Offer

Get 20% off

about ETPrime membership

Membership benefits

Get exclusive access to Economic Times

Stories, editorials and expert opinions

Full access with ET Prime

Enjoy the Economic Times the way you always liked it!

Find out where market gurus are investing and grow your portfolio.

Stock Exchange Report Plus

Detailed stock analysis for over 4,000 companies

Inventory Analyzer

Instant stock analysis based on solvency, profitability, growth, valuation, momentum, risk and other indicators.

Now available with ET Prime

Manage your money effectively with this weekly guide.

Pure experience

with minimal advertising

Easy, distraction-free reading with 90% fewer ads

Rich in sharp insight,

Detailed stories from over 20 sectors

Over 1,500 exclusive stories and analyses from a variety of sectors to help you stay up to date

Get 1 Year Times Prime Subscription Worth ₹1199 For Free

Get 1 Year Free TOI+ Subscription Worth Rs 799

Enjoy unlimited access to breaking news and inspiring stories from around the world.

Get a 1-year Docubay subscription worth ₹999 for free

Watch award-winning international documentaries from over 100 countries.

Offers from our partners

Exclusively for ET Prime members

Our members love us

Prominent industry players trust ET Prime for its insightful analysis and unbiased articles

Give the gift of history

Your membership includes Story Gifting Credits. Now gift exclusive stories to your friends and peers.

Comment and get involved

with the ET Prime community

Communicate and build relationships with the industry’s leading minds

Trusted team

Journalists and analysts

Unbiased perspectives and in-depth reporting from our team of journalists with in-depth knowledge and years of experience